ArticleJournal of cancer research and clinical oncology2021

Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens.

Fei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.